The Cooper Companies Company Profile
The Cooper Companies' consistent success is grounded in long-term strategies that provide its two medical device markets with high-quality, proprietary products that meet the needs of medical professionals and patients. CooperVision markets a broad range of contact lenses throughout the world. Over the past 5 years, CooperVision has consistently improved its market share in all the markets where it competes. CooperSurgical markets diagnostic products, surgical instruments and accessories for the women's healthcare market. CSI consolidates the highly fragmented women's healthcare market through acquisition, growing its position by expanding its product portfolio to better meet the needs of obstetricians and gynecologists. Important components of these business strategies include: Focus Cooper understands its customers and meets their changing needs with high-quality products and services that protect and grow their practices. Cooper stays close to patients through on-going consumer research and analysis that drives product development and marketing. For example, a significant part of CooperVision's recent success is the result of the company capitalizing on the segment of the contact lens market that is experiencing the most rapid growth – teenagers. Differentiation Cooper products deliver unique and measurable benefits. Consistent with this effort, CooperVision is a leader in the development of specialty and value-added contact lenses, one of the industry's fastest growing segments. Action Cooper is committed to improving its market position through product innovation and strategic acquisitions. Early in 2005, Cooper made its largest acquisition to date, Ocular Sciences, Inc., extending its product line and geographic presence, enhancing manufacturing technology and adding proprietary new materials for future products. In 2004, CooperSurgical acquired two obstetric and gynecologic product lines in the female incontinence market. Over the past 10 years, CooperSurgical has acquired more than 20 business and product lines to support its women's health franchise.
Location
21062 Bake Parkway, Suite 200
Lake Forest
CA
92630
United States of America
Contact
Phone: (949) 597-4700
Fax: (949) 768-3688
Email: ir@coopercompanies.com
News Articles
[Cooper Companies] buys [Origio] for NOK1.2bn
[Cooper Companies Inc.] has agreed to pay NOK1.2bn ($189mm) in cash for [Origio AS] (assisted reproduction technologies). It will pay NOK28 per share, a 71% premium. Formed in 1987 as MediCult AS, Or...
The Cooper Companies Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2013 09:30 AM
The Cooper Companies Inc. (COO) March 12, 2013 9:30 am ET Executives Gregory W. Matz - Chief Financial Officer and Vice President Analysts Matthew Taylor - Barclays Capital, Research Division...
Don't Lose Sight Of Cooper Companies
There are a lot of ways to play global population growth and emerging markets wealth creation. These secular trends are particularly important to healthcare investors, who are likely to benefit from a...
BRIEF-Cooper shares down 1.7 percent after the bell
NEW YORK, Dec 6 (Reuters) - Cooper Companies Inc : * Shares were down 1.7 percent after the bell following the release of its results.
The Cooper Cos. says FDA warning letter resolved
Eye care product maker The Cooper Cos. said Tuesday that it has addressed problems that led to a warning letter from regulators in December.The Food and Drug Administration sent Cooper a warning lett...
The Cooper Companies Announces Release Date for First Quarter 2013
The Cooper Companies, Inc. (NYSE:COO) today announced that it will release first quarter 2013 financial results on Thursday, March 7, 2013, at 4:00 PM ET. Following the release, t...
The Cooper Companies Announces Release Date for Third Quarter 2012
The Cooper Companies, Inc. (NYSE: COO) today announced that it will release third quarter 2012 financial results on Thursday, September 6, 2012 at 4:00 PM ET. Following the releas...
BRIEF-Cooper shares up 5.8 percent in extended trading
NEW YORK, Sept 6 (Reuters) - Cooper Companies Inc : * Shares up 5.8 percent in extended trading
Drugs and Medications
Oxygen [Promptcare Companies Inc.]
Oxygen
NEOSPORIN® Wound Cleanser
Desitin Maximum Strength Diaper Rash Paste
BAND-AID Brand HURT-FREE Antiseptic Wash
Clean & Clear Deep Cleaning Astringent
PubMed Articles
Think locally: evaluation of the microcirculation in sepsis.
A piece of my mind. Not born in the USA.
An option for the high-comorbidity patient with mitral regurgitation.
This article discusses clinical presentations and diagnostic approaches to acute coronary syndrome in the emergency department.
Astley cooper: his life and surgical contributions.
Sir Astley Paston Cooper (1768-1841) was a successful and influential British surgeon during the early decades of the 19th century. He was a dedicated anatomist, an accomplished researcher, an inspiri...
Clinical Trials
Effectiveness of a Vitamin Mineral Supplement
The goal of the study is to evaluate the effectiveness of a new one-a-day Cooper complete vitamin supplement with or without a combined omega-3 fatty acid supplement on selected clinical r...
Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse
This study will evaluate the effect of pessary therapy, with and without Solifenacin (Vesicare), on symptoms of over active bladder and bladder function in women with overactive bladder sy...
A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
This study will be co-ordinated by Dr Hector Chinoy, Dr Robert G Cooper (Salford Royal NHS Foundation Trust / The University of Manchester) and Dr Ian N Bruce (Central Manchester Universit...
Behavioral Treatment for Weight Loss
This project compares traditional behavioral therapy (based on Brownell's LEARN program for weight management, 2000) with acceptance-based behavioral therapy for weight loss (based on the...
Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to serving the needs of the healthcar...
The Cooper Companies' consistent success is grounded in long-term strategies that provide its two medical device markets with high-quality, proprietary products that meet the needs of medical professi...
CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. Dedicated to enhancing the contact lens experience for practitioners...
Delaware North Companies is one of the world's leading hospitality and food service providers. Its family of companies includes Delaware North Companies Parks & Resorts, Delaware North Companies Gamin...
More Information about "The Cooper Companies" on BioPortfolio
We have published hundreds of The Cooper Companies news stories on BioPortfolio along with dozens of The Cooper Companies Clinical Trials and PubMed Articles about The Cooper Companies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Cooper Companies Companies in our database. You can also find out about relevant The Cooper Companies Drugs and Medications on this site too.
